Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Long Term Provisions ₹123 Cr₹98 Cr₹80 Cr₹72 Cr₹63 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹123 Cr based on Mar2024 Consolidated results.
Year Long Term Provisions
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr
Mar2021₹72 Cr
Mar2020₹63 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr
10.74
Mar2021 ₹72 Cr
14.66
Mar2020 ₹63 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,468.7 Cr -4.1% -14.4% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,461.0 Cr 1.4% -4.1% 32.1% Stock Analytics
DIVIS LABORATORIES ₹147,983.0 Cr -4.2% -5.1% 59.6% Stock Analytics
CIPLA ₹112,735.0 Cr -2.2% -7.3% 0.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,913.9 Cr -7.1% -13.8% 8% Stock Analytics
ZYDUS LIFESCIENCES ₹92,815.0 Cr -6.4% -5.2% 31.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.1%

-14.4%

17%

SENSEX

-2.2%

-4%

5.5%


You may also like the below Video Courses